So ski, Do we think the DCVax-L/Keytruda combo trial is sponsored and paid for by UCLA/NIH (same with poly ICLC)? If yes, then this may explain why neither NWBO nor Merck (and Oncovir) have provided any comments/PRs/updates re the combo trials? Obviously, NWBO and Merck (and Oncovir) have been taking copius notes :-D